论文部分内容阅读
目的对采用不同方法对患有早期DIC的新生儿进行治疗的临床效果进行研究分析。方法抽取在过去一段时间内来我院就诊的66例患有早期DIC的新生儿患者病例,将其分为A、B两组,平均每组33例。A组患儿采用双嘧达莫进行治疗;B组患儿采用低分子肝素进行治疗。结果在治疗后B组患儿的PLT、AT-Ⅲ水平明显高于A组患儿;该组患儿的APTT、D-dimer水平明显低于A组患儿;两组患儿在治疗过程中均没有出现比较严重的并发症和不良反应现象。结论采用低分子肝素对患有早期DIC的新生儿进行治疗的临床效果十分明显,可以使相关生理指标的改变幅度进一步提高,在治疗过程中基本不会出现并发症和不良反应现象,在治疗后不会留有任何后遗症。
Objective To study the clinical effects of using different methods in the treatment of neonates with early DIC. Methods Sixty-six cases of neonates with early-stage DIC treated in our hospital in the past period were enrolled and divided into groups A and B, with an average of 33 cases in each group. A group of children treated with dipyridamole; B group of children with low molecular weight heparin for treatment. Results After treatment, the levels of PLT and AT-Ⅲ in group B were significantly higher than those in group A; the levels of APTT and D-dimer in group B were significantly lower than those in group A; None of the more serious complications and adverse reactions. Conclusions The clinical effect of using low molecular weight heparin to treat neonates with early DIC is very obvious, which can make the changes of related physiological indexes further improve. In the course of treatment, no complications and adverse reactions basically occur. After treatment Will not leave any sequelae.